FDA Inspection
Biomat USA IncBiomat USA Inc – FDA Inspection, Dec 13, 2013
Record Details
This FDA Inspection record concerns Biomat USA Inc, with an inspection on December 13, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA Inc
- Inspection Date
- December 13, 2013
- Product Type
- Biologics
View Company Profile
ID · 048082e8-3012-4221-85b2-f570893ec907
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 858689
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 30, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 9, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 22, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 28, 2010 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 6, 2009 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA Inc
- FDA Inspection 1034809 - 2017-10-30
- FDA Inspection 945282 - 2015-10-09
- FDA Inspection 787786 - 2012-06-22
- FDA Inspection 703347 - 2010-12-28
- FDA Inspection 567091 - 2009-03-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.